Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 48,000 shares at $23.23 ($1.1M) on 2017-06-07, disclosed to the SEC on 2017-06-09.
Open-market sale of $1.1M JUNO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.23 | 15,232 | $354K | 31.2% |
| 2 | $23.23 | 15,232 | $354K | 31.2% |
| 3 | $24.24 | 8,768 | $213K | 18.8% |
| 4 | $24.24 | 8,768 | $213K | 18.8% |
| Total | $23.60 avg | 48,000 | $1.1M | 100% |
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |